Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

Share Price is delayed by 15 minutes
Get Live Data
45.85    0.05 (0.11%)
Bid:
45.60
Ask:
45.90
Spread: 0.30 (0.658%)
Market Cap: £290.17m
MARS Live PriceLast checked at - London Stock Exchange

Intraday Marstons Share Chart

Form 8.5 (EPT/RI) Martson's Plc - Amendment

8 Feb 2021 10:00

RNS Number : 3070O
Peel Hunt LLP
08 February 2021
Β 

FORM 8.5 (EPT/RI)

Β 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

Β 

Form 8.5 (EPT/RI) - Marston's Plc announcement released on 05/02/2021 at 12:00 under RNS No 1575O has been amended.

Β 

Amendments are identified with an asterisk (*).

Β 

The full amended text is shown below.

Β 

Β 

1. KEY INFORMATION

Β 

(a) Name of exempt principal trader:

Peel Hunt LLP

(b) Name of offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Marston's Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Marston's Plc

(d) Date dealing undertaken:

04 February 2021

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

Β 

N/A

Β 

Β 

Β 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

Β 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

Β 

(a) Purchases and sales

Β 

Class of relevant security

Purchases/ sales

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Ordinary Shares

Buy

1,132,406*

96.78 GBx

93.65 GBx

Ordinary Shares

Sell

1,144,744

96.79 GBx

94.18 GBx

Β 

Β (b) Cash-settled derivative transactions

Β 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Β 

(c) Stock-settled derivative transactions (including options)

Β 

(i) Writing, selling, purchasing or varying

Β 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

Β 

(ii) Exercise

Β 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

Β 

(d) Other dealings (including subscribing for new securities)

Β 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

Β 

Β 

3. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

Β 

Β 

Β 

Β 

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

Β 

If there are no such agreements, arrangements or understandings, state "none"

Β 

Β 

Β 

Β 

Date of disclosure:

08 February 2021

Β 

Contact name:

Kathleen Lloyd

Telephone number:

0207 418 8911

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
FERBGGDDGGGDGBI
Date   Source Headline
2nd Feb 20152:53 pmRNSTotal Voting Rights
28th Jan 201511:59 amRNSResult of AGM
27th Jan 20157:00 amRNSAGM And Trading Statement
13th Jan 201510:09 amRNSBlocklisting Interim Review
6th Jan 20154:51 pmRNSHolding(s) in Company
2nd Jan 201510:37 amRNSTotal Voting Rights
24th Dec 201410:55 amRNSDirector/PDMR Shareholding
18th Dec 20141:46 pmRNSAnnual Financial Report
9th Dec 201410:07 amRNSHolding(s) in Company
1st Dec 20145:24 pmRNSTotal Voting Rights
27th Nov 20147:00 amRNSPreliminary Results
18th Nov 20145:41 pmRNSHolding(s) in Company
3rd Nov 20142:10 pmRNSTotal Voting Rights
8th Oct 20147:00 amRNSYear-end trading update
2nd Oct 201411:19 amRNSTotal Voting Rights
26th Sep 201411:00 amRNSHolding(s) in Company
18th Sep 20149:47 amRNSDirectorate Change
16th Sep 201410:01 amRNSHolding(s) in Company
10th Sep 20149:21 amRNSHolding(s) in Company
9th Sep 20144:51 pmRNSHolding(s) in Company
5th Sep 20147:00 amRNSBoard Appointments
1st Sep 20144:41 pmRNSTotal Voting Rights
1st Aug 20142:52 pmRNSTotal Voting Rights
24th Jul 20147:00 amRNSInterim Management Statement
21st Jul 201412:13 pmRNSHolding(s) in Company
10th Jul 20143:06 pmRNSBlocklisting Interim Review
4th Jul 201410:57 amRNSTotal Voting Rights
1st Jul 20143:56 pmRNSTotal Voting Rights
26th Jun 20143:01 pmRNSDirector/PDMR Shareholding
25th Jun 20142:22 pmRNSHolding(s) in Company
25th Jun 20141:40 pmRNSDirector/PDMR Shareholding
18th Jun 201410:29 amRNSDirector/PDMR Shareholding
3rd Jun 20143:22 pmRNSTotal Voting Rights
19th May 20144:34 pmRNSDirector/PDMR Shareholding
15th May 20147:00 amRNSInterim Results
1st May 20141:12 pmRNSTotal Voting Rights
1st Apr 201411:23 amRNSTotal Voting Rights
3rd Mar 20142:06 pmRNSTotal Voting Rights
28th Feb 201412:22 pmRNSDirector/PDMR Shareholding
27th Feb 201411:40 amRNSHolding(s) in Company
3rd Feb 20143:50 pmRNSTotal Voting Rights
21st Jan 20144:16 pmRNSResult of AGM
21st Jan 20147:00 amRNSAGM and Interim Management Statement
13th Jan 201410:13 amRNSBlocklisting Interim Review
6th Jan 201411:45 amRNSHolding(s) in Company
2nd Jan 20143:47 pmRNSTotal Voting Rights
17th Dec 20134:37 pmRNSAnnual Financial Report
5th Dec 201310:09 amRNSDirector/PDMR Shareholding
2nd Dec 20134:14 pmRNSTotal Voting Rights
28th Nov 20137:00 amRNSNewRiver acquires portfolio for retail conversion

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.